{"id":4483,"date":"2020-12-08T15:27:40","date_gmt":"2020-12-08T04:57:40","guid":{"rendered":"https:\/\/strawman.com\/blog\/?p=4483"},"modified":"2020-12-08T15:27:41","modified_gmt":"2020-12-08T04:57:41","slug":"could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments","status":"publish","type":"post","link":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/","title":{"rendered":"Could Creso Pharma significantly benefit from US Marijuana Act developments?"},"content":{"rendered":"\n<p class=\"has-drop-cap\">Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act.<\/p>\n\n\n\n<p>The North American cannabis industry projects widespread benefits from this decision to decriminalise cannabis (note the bill must pass through the Senate), encouraging investors and corporate America to fully unlock the value of a multi-billion dollar industry, expected to surge to <a href=\"https:\/\/mjbizdaily.com\/chart-us-cannabis-industrys-economic-impact-could-hit-130-billion-by-2024\/\">$130BN by 2024<\/a>.<\/p>\n\n\n\n<p>Global cannabis grower and CBD product developer <strong>Creso Pharma Limited<\/strong> (ASX:CPH; FRA:1X8) looks to be one of the best placed ASX listed companies to capitalise on significant growth opportunities in the US market.<\/p>\n\n\n\n<p>The company has an established global distribution network that will benefit from the ruling, as well as a leading Canadian subsidiary, Mernova Medicinal Inc. <\/p>\n\n\n\n<p>Mernova is Creso\u2019s 100% owned, full licensed, 24,000 sq.ft cannabis growing facility in Canada, only 1,700 miles from the US border, an ideal location to be able to cater to the Canadian and US market.<\/p>\n\n\n\n<p>This growing facility is already in operation and generating revenues, with a number of Purchase Orders signed in recent months, including circa $320,000 from one client alone.<\/p>\n\n\n\n<p>In late October, CPH received and successfully delivered its third purchase order (PO) from the Nova Scotia Liquor Corporation (NSLC).<\/p>\n\n\n\n<p>The third PO is for 20 cases of Mernova\u2019s \u2018Mimosa\u2019 (15-20% THC, less than 1% CBD) strain which is Mernova\u2019s value brand now launched under the Ritual Green brand.<\/p>\n\n\n\n<p>It also received a second purchase order from Pharma Dynamics for CPH\u2019s cannaQIX\u00ae product \u2013 sold under the \u2018Cannamics\u2019 brand. This followed the successful product launch into the South African market in March 2020.<\/p>\n\n\n\n<p>With the US market now on its radar, Mernova can scale up operations to meet potential demand from this market, and will benefit directly upon legislation passing \u2013 if and when it occurs. <\/p>\n\n\n\n<p>Creso has also recently appointed Canadian cannabis icon Bruce Linton as a Strategic Advisor. Mr Linton was the founder and CEO of Canopy Growth (TSX: WEED | NYSE: CGC), which he built from a tiny start up into a US$15BN market cap powerhouse at its peak.<\/p>\n\n\n\n<p>Mr Linton\u2019s presence will also facilitate Creso\u2019s expansion into the US market. <\/p>\n\n\n\n<p>There is already substantial appetite for the group\u2019s Swiss CBD products in the US, the world\u2019s largest recreational and medical cannabis market. <\/p>\n\n\n\n<p>Creso is now exploring several initiatives to roll its products out as soon as legislation occurs. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Purchase orders multiply in Europe<\/h4>\n\n\n\n<p>In Europe, CPH continues to sell its CBD products in the animal health market via its Swiss operations, with a total of A$975,000 in Purchase Orders confirmed. <\/p>\n\n\n\n<p>Europe has undertaken its own legislative overhaul.<\/p>\n\n\n\n<p>On 19 November 2020, the Court of Justice of the European Union (CJEU) ruled that member states must not prohibit the marketing of lawfully produced CBD.<\/p>\n\n\n\n<p>The CJEU ruled that CBD is not considered a narcotic, and as a result, CBD can be freely sold in the European Union (EU).<\/p>\n\n\n\n<p>This decision has the potential to provide significant benefits to Creso Pharma, particularly given the company already has commercial agreements in place in the region.<\/p>\n\n\n\n<p>In August, Creso Pharma signed a commercial agreement with DHS Business Portugal to introduce the group\u2019s products into the Portuguese and Spanish markets, effectively expanding the company\u2019s presence in Europe.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Global regulatory developments cause CPH share price surge<\/h4>\n\n\n\n<p>Last week\u2019s <a href=\"https:\/\/finfeed.com\/small-caps\/juniors\/creso-pharma-poised-cash-cbd-regulatory-changes\/\">regulatory shifts in the European Union<\/a> and <a href=\"https:\/\/finfeed.com\/small-caps\/juniors\/united-nations-reclassifies-cannabis-far-reaching-landmark-decision\/\">United Nations reclassification of cannabis<\/a> add further significance to current developments. <\/p>\n\n\n\n<p>Creso co-founder and Director Boaz Wachtel highlighted, \u201cThis is a historic ruling that will create significant growth opportunities in our burgeoning industry. It follows similar regulatory shifts in the European Union and from the United Nations that highlight public acceptance for cannabis and CBD-derived products is at an all-time high.<\/p>\n\n\n\n<p>\u201cThe company has a robust balance sheet, allowing it to progress near and medium term growth initiatives, as well as an established Canadian subsidiary in Mernova, which can be scaled up to address the US market.<\/p>\n\n\n\n<p>\u201cThe appointment of Canopy Growth founder, Bruce Linton to Creso earlier this year will position Creso very strongly to take advantage of this new opportunity when it materialises.\u201d<\/p>\n\n\n\n<p>\u201cCreso is very well positioned to capitalise on opportunities arising from the market in the USA.<\/p>\n\n\n\n<p>\u201cThe company has a robust balance sheet, allowing it to progress near and medium term growth initiatives, as well as an established Canadian subsidiary in Mernova, which can be scaled up to address the US market.\u201d<\/p>\n\n\n\n<p>Such vantage is mirrored by CHP\u2019s significant market interest in recent weeks, increasing more than threefold in less than a fortnight. <\/p>\n\n\n\n<p>With shares surging from 3c to as much as 22c today, CPH is currently trading at levels not seen since February 2020 when COVID sent global markets tumbling. <\/p>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p class=\"has-text-color has-cyan-bluish-gray-color\"><em><strong>Disclaimer\u2013<\/strong> <\/em> <em>This content was produced and paid for by StocksDigital. The author may hold positions in the stocks mentioned in this publication, at the time of writing. The information contained in the publication and the links shared are general in nature and does not take into account your personal situation. You should consider whether the information is appropriate to your needs, and where appropriate, seek professional advice from a financial adviser. For errors that warrant correction please contact the editor at admin@strawman.com.<\/em><\/p>\n\n\n\n<p class=\"has-text-color has-background has-text-align-center has-very-dark-gray-color has-very-light-gray-background-color\"><em>Strawman is Australia&#8217;s premier online investment club. Join for free to access independent &amp; actionable recommendations from proven private investors.<\/em><br><\/p>\n\n\n\n<div class=\"wp-block-button aligncenter\"><a class=\"wp-block-button__link has-text-color has-very-light-gray-color has-background has-tertiary-background-color\" href=\"https:\/\/strawman.com\/member\/landing\/signup\">Register for free ASX recommendations<\/a><\/div>\n\n\n\n<hr class=\"wp-block-separator\"\/>\n\n\n\n<p class=\"has-text-color has-text-align-center has-cyan-bluish-gray-color\">\u00a9 2020 Strawman Pty Ltd. All rights reserved.<\/p>\n\n\n\n<p class=\"has-text-align-center\">| <a href=\"https:\/\/strawman.com\/member\/landing\/privacy\">Privacy Policy<\/a>&nbsp;|&nbsp;<a href=\"https:\/\/strawman.com\/member\/landing\/terms\">Terms of Service<\/a> | <a href=\"https:\/\/strawman.com\/member\/landing\/fsg\">Financial Services Guide<\/a> | <\/p>\n\n\n\n<p class=\"has-text-color has-text-align-center has-cyan-bluish-gray-color\">ACN: 610 908 211 <strong>Could Creso Pharma significantly benefit from US Marijuana Act developments?<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act. The North American cannabis industry projects widespread benefits from this decision to decriminalise cannabis (note the bill must pass [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":4484,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[100],"tags":[],"class_list":["post-4483","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sponsored"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog\" \/>\n<meta property=\"og:description\" content=\"Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act. The North American cannabis industry projects widespread benefits from this decision to decriminalise cannabis (note the bill must pass [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/\" \/>\n<meta property=\"og:site_name\" content=\"Strawman Blog\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-08T04:57:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-08T04:57:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2208\" \/>\n\t<meta property=\"og:image:height\" content=\"1443\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jonathan Jackson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jonathan Jackson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/\"},\"author\":{\"name\":\"Jonathan Jackson\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/#\\\/schema\\\/person\\\/27228d008a7ce9d1016b82a73f3cc8a9\"},\"headline\":\"Could Creso Pharma significantly benefit from US Marijuana Act developments?\",\"datePublished\":\"2020-12-08T04:57:40+00:00\",\"dateModified\":\"2020-12-08T04:57:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/\"},\"wordCount\":952,\"image\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/strawman.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/creso.jpg\",\"articleSection\":[\"Sponsored\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/\",\"url\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/\",\"name\":\"Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/strawman.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/creso.jpg\",\"datePublished\":\"2020-12-08T04:57:40+00:00\",\"dateModified\":\"2020-12-08T04:57:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/#\\\/schema\\\/person\\\/27228d008a7ce9d1016b82a73f3cc8a9\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/strawman.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/creso.jpg\",\"contentUrl\":\"https:\\\/\\\/strawman.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/creso.jpg\",\"width\":2208,\"height\":1443},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/strawman.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Could Creso Pharma significantly benefit from US Marijuana Act developments?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/strawman.com\\\/blog\\\/\",\"name\":\"Strawman Blog\",\"description\":\"The Last Straw\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/strawman.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/strawman.com\\\/blog\\\/#\\\/schema\\\/person\\\/27228d008a7ce9d1016b82a73f3cc8a9\",\"name\":\"Jonathan Jackson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g\",\"caption\":\"Jonathan Jackson\"},\"url\":\"https:\\\/\\\/strawman.com\\\/blog\\\/author\\\/jonathan-jackson\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/","og_locale":"en_US","og_type":"article","og_title":"Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog","og_description":"Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act. The North American cannabis industry projects widespread benefits from this decision to decriminalise cannabis (note the bill must pass [&hellip;]","og_url":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/","og_site_name":"Strawman Blog","article_published_time":"2020-12-08T04:57:40+00:00","article_modified_time":"2020-12-08T04:57:41+00:00","og_image":[{"width":2208,"height":1443,"url":"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg","type":"image\/jpeg"}],"author":"Jonathan Jackson","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jonathan Jackson","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#article","isPartOf":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/"},"author":{"name":"Jonathan Jackson","@id":"https:\/\/strawman.com\/blog\/#\/schema\/person\/27228d008a7ce9d1016b82a73f3cc8a9"},"headline":"Could Creso Pharma significantly benefit from US Marijuana Act developments?","datePublished":"2020-12-08T04:57:40+00:00","dateModified":"2020-12-08T04:57:41+00:00","mainEntityOfPage":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/"},"wordCount":952,"image":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg","articleSection":["Sponsored"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/","url":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/","name":"Could Creso Pharma significantly benefit from US Marijuana Act developments? - Strawman Blog","isPartOf":{"@id":"https:\/\/strawman.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#primaryimage"},"image":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg","datePublished":"2020-12-08T04:57:40+00:00","dateModified":"2020-12-08T04:57:41+00:00","author":{"@id":"https:\/\/strawman.com\/blog\/#\/schema\/person\/27228d008a7ce9d1016b82a73f3cc8a9"},"breadcrumb":{"@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#primaryimage","url":"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg","contentUrl":"https:\/\/strawman.com\/blog\/wp-content\/uploads\/2020\/12\/creso.jpg","width":2208,"height":1443},{"@type":"BreadcrumbList","@id":"https:\/\/strawman.com\/blog\/could-creso-pharma-significantly-benefit-from-us-marijuana-act-developments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/strawman.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Could Creso Pharma significantly benefit from US Marijuana Act developments?"}]},{"@type":"WebSite","@id":"https:\/\/strawman.com\/blog\/#website","url":"https:\/\/strawman.com\/blog\/","name":"Strawman Blog","description":"The Last Straw","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/strawman.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/strawman.com\/blog\/#\/schema\/person\/27228d008a7ce9d1016b82a73f3cc8a9","name":"Jonathan Jackson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d688b39bbcec6fa415d278ba382020c5be4504503c5f8a6dca538a3c827d5aeb?s=96&d=robohash&r=g","caption":"Jonathan Jackson"},"url":"https:\/\/strawman.com\/blog\/author\/jonathan-jackson\/"}]}},"_links":{"self":[{"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/posts\/4483","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/comments?post=4483"}],"version-history":[{"count":0,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/posts\/4483\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/media\/4484"}],"wp:attachment":[{"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/media?parent=4483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/categories?post=4483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/strawman.com\/blog\/wp-json\/wp\/v2\/tags?post=4483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}